The contribution of early virus-induced epigenetic changes to human papillomavirus (HPV)-associated carcinogenesis is poorly understood. Using genome-wide methylation array profiling and a cell-based model, which supports replication of HPV episomes, we found that transfection of primary human foreskin keratinocytes with episomal forms of high-risk HPV types was followed by upregulation of the DNA methyltransferases, DNMT1 and DNMT3B, and changes in the methylation status of cellular genes many of which are reported to be differentially methylated in cervical neoplasia. HPV16-and HPV18-associated changes were not randomly distributed across the genome, but clustered at specific chromosomal locations which mapped on to known HPV integration sites and to chromosomal regions lost and gained in highgrade cervical neoplasia. Methylation changes were directed in part by the same cis-acting factors that appear to direct methylation changes in cancer, the presence of a bivalent chromatin mark in human embryonic stem cells and promoter CpG content; these associations explain much of the ontological profile of genes found to have increased methylation following HPV16 transfection. We were also able to show, using sequential samples from a cohort of young women with incident HPV16 infections, that the detection in cervical samples of methylated forms of the tumour suppressor gene, RARB, often parallels the natural history of cervical HPV infection. Our findings suggest that further investigation of the distribution and determinants of early virus-induced epigenetic reprogramming will provide important insights into the pathogenesis of virus-associated malignancy.
Introduction
DNA methylation in mammalian cells occurs at the 5′-position of cytosine within CpG dinucleotides. Although under-represented across the genome, CpG dinucleotides are enriched in CpG islands that are genomic regions of about 1 kilobase found within or near promoters or first exons in approximately 70% of human genes (1) . Although the ordered imposition and removal of DNA methylation is critical for embryonic development, X-chromosome inactivation, parental imprinting and cellular differentiation, aberrant DNA methylation also contributes to cancer initiation and progression.
DNA methylation is catalysed by three DNA methyltransferases: DNMT1, DNMT3A and DNMT3B (2) . Oncogenic viruses including hepatitis B, hepatitis C, Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus (EBV) are known to interact with, and to modulate the expression of the DNMT, resulting in the transactivation and transrepression of both cellular and viral genes (3) (4) (5) (6) (7) (8) . The HPV16 oncoproteins, E6 and E7, have been shown to increase the expression and activity of DNMT1; the former through suppression of p53, and the latter through disruption of the pRB/E2F pathway that regulates the DNMT1 promoter (9) (10) (11) . However, the contribution of early virusinduced methylation changes to HPV-associated carcinogenesis, if any, remains uncertain (12, 13) . Henken et al. (2007) , for example, found that keratinocytes containing integrated forms of high-risk HPV types only begin to accumulate methylation changes following immortalization (14) . Apostilodou et al. (2010) commenting on the failure to detect methylation differences in cervical smears taken from HPV positive and HPV negative disease-free women speculated that HPV infection per se is not the driving force for the majority of DNA methylation alterations observed in early cervical neoplasia (15, 16) .
Therefore, in this study, we define using genome-wide promoter arrays, the topographical distribution of the methylation changes that follow the transfection of primary human foreskin keratinocytes (PHFK) with HPV16 and HPV18 using a virus replication model which unlike that shown previously supports replication of viral episomes (17) . We investigate the determinants of this distribution, and the potential implications of these methylation changes for HPV-associated carcinogenesis. Finally, we determine using sequential observations generated by a well-characterized cohort of young women who had recently embarked on sexual activity how the detection of methylated forms of a tumour suppressor gene implicated in cervical carcinogenesis varies with the natural history of cervical HPV infection.
Materials and methods

Transfection of PHFK with HPV16 and HPV18 genomes
Early passage neonatal PHFK isolated from a single donor were co-transfected with recircularized genomes of either HPV16 (clone 114/B) (kindly provided by E-M de Villiers, DKFZ, Heidelberg, Germany) or HPV18 and a plasmid containing a neomycin resistance gene, as described previously (18, 19) . After a brief selection of cells in G418-and serum-containing media, emergent colonies were pooled and cultured without drug selection for between 6 and 9 population doublings on gamma-irradiated J2 3T3 fibroblasts feeders prior to extraction of genomic DNA. The presence of episomal forms of the HPV genomes was confirmed by the assessment of E2 integrity and by Southern blot, as described previously (20) . Organotypic raft cultures were prepared as shown previously (19) and harvested after 13 days of growth. After fixation in formaldehyde, the rafts were embedded in paraffin and 4 μm sections stained with haematoxylin and eosin to assess morphology (Propath UK Ltd). For immunohistochemistry, slides were de-paraffinized, and low-temperature antigen retrieval was performed as described previously (21) . DNMT1 was detected using the rabbit polyclonal antibody (ab19905, Abcam), the specificity of which was confirmed using a blocking peptide (ab21999, Abcam). DNMT3B was detected using the rabbit polyclonal antibody (HPA001595, Sigma); no blocking peptide is available for this antibody but its specificity has already been confirmed using protein arrays (22) .
Methylation microarray experiments
Genomic DNA was isolated from untransfected PHFK and from PHFK transfected with HPV16 or HPV18 using cell lysis, standard phenol/chloroform extraction and ethanol precipitation. DNA quantity and quality was analysed using a Nanodrop ND-1000 spectrophotometer and an Agilent Bioanlayzer, respectively; both untransfected and transfected passages were found to be of high-quality. Methylated DNA was immunoprecipitated (MeDIP) using the MethylCollector™ Ultra kit (Active Motif). Whole-genomic DNA amplification was performed on methyl enriched samples before fragmentation and hybridization to promoter tiling arrays (Affymetrix).
Cel files were generated using scanned images of microarray chips and the Affymetrix GeneChip Operating Software, and analysed using the TileMap software (23) . Probe-level data were quantile-normalized and probe-level test statistics for two-sample comparisons calculated using a hierarchical empirical Bayes model. The hidden state of each probe was inferred using unbalanced mixture subtraction and hidden Markov model algorithms with the posterior probability cut-off set to 0.5. The Tilemap peak detection algorithm was used to detect hypomethylated and hypermethylated regions. These regions were required to contain at least 11 probes. Regions shorter than 100 bp or those containing less than five continuous probes passing the cut-off were discarded. Adjacent regions were merged when the gap between them was less than 201 bp and the number of intervening probes failing to pass the cut-off less than 6. No further cut-offs Carcinogenesis vol.33 no.7 pp.1286-1293, 2012 doi:10.1093/carcin/bgs157 Advance Access Publication May 2, 2012 were applied. When calculating the false discovery rate, unbalanced mixture subtraction was used. All probe sequences were mapped to the genome assembly (Hg18). Genomic regions were visualized using the Affymetrix Integrated Human Genome browser. The methylation array was validated by performing MeDIP-coupled quantitative-PCR (Q-PCR) on 17 genes. When validating methylation changes predicted on the array, primers were designed within the region of predicted change, using primer3 design software. Each Q-PCR reaction was performed using 12.5 µl SYBR green Q-PCR master mix (Qiagen), 20 ng of methyl enriched DNA and 7.5 pmol of primers (SupplementaryTable S1 is available at Carcinogenesis Online). Q-PCR assays were performed in triplicate using an ABI Prism 7700 sequence detection system (Applied Biosystems). The computer programme R was used for simulating the distribution of concordantly methylated genes, and the probability of the observed number of adjacent genes showing similar changes in methylation status was calculated using the binomial distribution. When exploring the determinants of methylation change, estimates of association for categorical data were obtained using odds ratios, with chi-squared statistics and P-values calculated as appropriate.
Detection of methylated forms of RARB in cervical samples using nested quantitative methylation-specific PCR (Q-MSP)
Study design. The study design and characteristics of the study population have been described elsewhere (20, 24) . In brief, 2011 women aged 15-19 years were recruited from a single Brook Advisory Centre (a family planning clinic) in Birmingham, UK, between 1988 and 1992, and asked to re-attend at intervals of 6 months; follow-up ended on 31 August 1997. At recruitment, a standardized interview questionnaire was used to construct a detailed social, sexual and behavioural risk-factor profile, including smoking. Sexual and smoking histories were updated at each follow-up visit. In addition, at each visit, two cervical cytological samples were taken using the same Ayres spatula; the first was used to prepare a smear for immediate cytological evaluation and the second was placed into 10 ml of phosphate buffered saline and stored at −80°C for subsequent virological examination. All women in whom a cervical cytological abnormality was identified were immediately referred to a dedicated research clinic for histological examination, irrespective of the severity of that abnormality. Colposcopic and cytological surveillance were maintained in these women, and treatment was postponed, until there was histological evidence of high-grade cervical intraepithelial neoplasia (CIN2 or CIN3), at which point women left the study.
Ethical approval. Informed oral consent was obtained from all women by one of only two gynaecological clinical research fellows who were involved in subject recruitment and in the management of patients with cytological abnormality. Cervical samples. From our natural history cohort, we had identified a subset (n 5 60) of women in whom Q-PCR had previously been used to measure virus copy number in serial samples following an incident HPV16 infection. From this subset, 23 women were selected for an investigation of how the detection of methylated forms of TSG changed following the first detection of HPV16 DNA or with 'clearance' of the cervical infection (24) . Of the 23 women potentially contributing to the analysis of incident infection, two were excluded because their first HPV positive sample either tested negative for the house-keeping gene GAPDH or insufficient DNA from this sample was available for testing. Of the 19 women potentially contributing to the analysis of clearance of HPV16 infection, three were excluded because there was insufficient DNA for testing in either their last HPV positive or their first HPV negative sample.
Nested Q-MSP. A total of 149 cervical samples were tested for methylated forms of RARB. Genomic DNA (200 ng) was bisulphite converted using the EZ DNA methylation kit (Zymo Research). The nested Q-MSP method along with the primers and probes used in this analysis were as described in Fackler et al. (2004) (25) . In the first PCR reaction, 10 µl of bisulphite DNA was added to 25 µl of PCR master mix (Promega) and 25 pmol of forward and reverse nested PCR primers. The PCR products were measured following purification (Qiagen) and 20 ng of product was added to Q-MSP reaction buffer containing 12.5 µl Taqman master mix (Applied Biosystems), 10 pmol of methylated or unmethylated primers and 2 pmol of methylated or unmethylated probe. Assays were performed in triplicate using an ABI Prism 7700 sequence detection system (Applied Biosystems). For each reaction plate, the following were used to generate standard curves and to provide controls: (i) serially diluted methylated and unmethylated copy number standards (ii) no template control and (iii) SiHa (a known methylated control). The percentage of methylation was calculated as: percentage methylated 5 100 × [number of copies of methylated DNA/(number of copies of methylated DNA + number of copies of unmethylated DNA)]. Wilcoxon tests were used when comparing these continuous data.
Results
Changes in the pattern of expression of the DNA methyltransferases in organotypic rafts established following HPV transfection of PHFK recapitulates that observed in cervical neoplasia
In PHFK organotypic rafts, DNMT1 expression is restricted to nuclei of cells of the basal and early differentiating layers but downregulated in more differentiated cells. However, in rafts established following transfection of PHFK with HPV18, DNMT1 nuclear staining is seen not only in the basal layer but also in suprabasal cells extending to the stratum granulosum, with intense DNMT1 staining in some of these cells. Changes in the topography of DNMT3B expression were similar to those observed for DNMT1, although the overall intensity of staining was weaker ( Figure 1 ). No consistent changes were seen in the expression of DNMT3A in organotypic rafts following HPV transfection (data not shown).
Transfection of PHFK with episomal forms of high-risk HPV is followed by widespread methylation changes in cellular genes
To investigate the consequences of these HPV-induced changes in the expression of the DNA methyltransferases, genome-wide methylation profiling was performed on PHFK following their transfection with episomal forms of HPV16 and HPV18. Table I reveals a significant increase in the methylation of 5607 and 2837 genes, following transfection of PHFK with HPV16 and HPV18, respectively; a decrease in the methylation of 3568 and 4160 genes and both an increase and a decrease in methylation in non-overlapping regions in a further 2295 and 1023 genes (Table I) . Of those genes found to have either increased or decreased methylation following transfection with HPV18, 87% and 63%, respectively, were concordantly changed following HPV16 transfection. Methyl enriched Q-PCR confirmed the changes in methylation status predicted on the promoter array in all 17 genes selected for further validation ( Figure 2 ). These 17 genes were selected for further validation because they had either been reported to be methylated in cervical neoplasia, or they were components of the WNT signalling pathway which is known to be disrupted in cervical neoplasia, or were themselves epigenetic regulators (Supplementary Table S2 is available at Carcinogenesis Online) (26) . 
HPV-induced methylation changes
Genes with increased methylation following transfection with either episomal HPV16 or HPV18, or both, were enriched for those identified in candidate gene studies as aberrantly methylated in cervical neoplasia (OR 5 2.0, χ 2 (1 df) 5 9.7, P 5 0.0019, Supplementary Table S2 , which lists all publications describing methylated forms of genes methylated in cervical neoplasia, is available at Carcinogenesis Online). We also determined the frequency with which genes found to be differentially methylated by HPV18 in our initial methylation analysis were also differentially methylated in three other donors (A, B and C), which had previously been transfected with HPV18 (27) . For a number of these genes, concordant changes in methylation status were seen in keratinocytes isolated in these additional donors (SupplementaryFigure S1 is available at Carcinogenesis Online). For example, hypomethylation of SFRP1 and DLC1 was confirmed in all four donors and hypermethylation of CADM1 and MBD1 in three.
Methylation 'hotspots' map on to HPV integration sites and chromosomal regions lost in high-grade cervical neoplasia
Although earlier candidate gene studies suggested that hypermethylation events are focal in nature, recent genome-wide surveys have revealed that co-ordinated methylation changes over large regions are a common phenomenon at different sites of cancer (28, 29) . When we looked for evidence of clustering of methylation changes in HPV-transfected PHFK, we found that 64% and 50% of those genes with increased methylation following HPV16 and HPV18 transfection, respectively, were in clusters consisting of two or more adjacent genes that were concordantly changed. Of genes found to have decreased methylation following transfection with HPV16 or HPV18, 49% and 53%, respectively, were similarly clustered. For both hypermethylated and hypomethylated genes, the probability of observing this proportion of adjacent genes with a concordant change in methylation status, or one greater is less than 1 in 100 000, suggesting that HPV16-and HPV18-associated methylation changes are non-randomly distributed across the genome (Supplementary Figure S2 is available at Carcinogenesis Online). We next explored whether methylation changes clustered at certain cytogenetic locations. A cytoband was considered a methylation hotspot when it included significantly (P  0.001) more genes with either increased or decreased methylation following HPV transfection than would have been expected from the overall frequency of these changes observed on the array. Of 806 cytobands listed on the array, 36 and 35 were found to be HPV16 and HPV18 hypermethylation hotspots, respectively, with 23 of these hotspots common to both HPV types; 27 HPV16 and 16 HPV18 hypomethylation hotspots were also identified of which 9 were common to both types ( Figure 3A and B, Supplementary Table S3A is available at Carcinogenesis Online). Furthermore, HPV-associated hypermethylation hotspots appear to cluster in telomeric regions.
Consistent with recent evidence that epigenetic and genetic changes are globally co-ordinated, and with the possibility that early HPVinduced epigenetic changes may predispose to later genetic events relevant to virus-associated carcinogenesis, we found that HPV16-associated hypermethylation hotspots were enriched for sites where HPV is known to be integrated into the genome (OR 5 2.4, χ 2 (1 df) 5 5.012, P 5 0.0252, Figure 3C , Supplementary Table S3B is available at Carcinogenesis Online) (30) (31) (32) (33) (34) (35) . We also found that HPV16 and HPV18 hypermethylation hotspots were enriched for regions of chromosomal loss previously identified in women with high-grade CIN using comparative genomic hybridization (HPV16 hotspots: OR 5 4.9, χ 2 (1 df) 5 7.1, P 5 0.0078; HPV18 hotspots: OR 5 10.5, χ 2 (1 df) 5 26.3, P  0.0001, Figure 3D , Supplementary Table S3C is available at Carcinogenesis Online) (36) (37) (38) . Of the 27 HPV16 and 16 HPV18 hypomethylation hotspots identified, 6 were also listed as regions of amplification in the same analysis of women with high-grade CIN; HPV16 but not HPV18 hypomethylation hotspots were enriched for these regions of amplification (χ 2 (1 df) 5 4.98, P  0.05) (Supplementary Table S3D is available at Carcinogenesis Online).
The same cis-acting factors which direct DNA methylation in cancer determine the distribution of methylation changes in HPV-transfected PHFK As these results are consistent with the possibility that HPV-associated methylation changes may like those described in cancer come about through an instructive mechanism, we looked for cis-acting factors that might determine their distribution. In melanoma, prostate cancer and in non-Hodgkin's lymphomas, genome-wide analyses show that those genes that become hypermethylated in cancer are significantly more likely to have a high CpG content whereas those that become hypomethylated have a low CpG content (39) (40) (41) . Using the same classification of overall promoter CpG content first reported by Weber et al. HPV-induced methylation changes P < 0.0001, Table II (42)]. Similar trends were seen following HPV18 transfection (SupplementaryTable S4 is available at Carcinogenesis Online).
In both cancer and ageing, aberrantly hypermethylated promoters have been associated with a key set of developmentally regulated genes that are held in a 'transcription-ready' state in embryonic stem cells by a bivalent promoter chromatin pattern consisting of the active histone mark, H3K4me3, and the repressive mark, H3K27me3 (43) (44) (45) (46) (47) . Using a published genome-wide map of these histone modifications in human embryonic stem (HES) cells, we found that bivalently marked genes are more likely to have increased methylation and less likely to have decreased methylation following transfection of PHFK with episomal HPV16 (χ 2 (2 df) 5 254, P  0.0001; χ 2 (2 df) 5 71.2, P  0.0001, Table II (47) . Consistent with these findings, genes with increased methylation following HPV16 transfection were also found to be enriched for a subset of polycomb target genes found to undergo methylation with age and to be significantly more methylated in cervical smears taken from women with HPV-associated CIN than in normal cervical cells (OR 5 2.9, χ 2 (1 df) 5 19.9, P  0.0001, Supplementary Table S5 is available at Carcinogenesis Online) (48) .
Although genes with a high CpG content are more likely to be bivalently marked in HES cells than those with a low CpG content (χ 2 (1 df) 5 289.1, P  0.0001), both CpG content and the presence of a bivalent chromatin mark in HES cells appear to be independent predictors of methylation changes in HPV16-transfected PHFK (Table III) .
The detection of methylated forms of RARB parallels the natural history of cervical HPV infection in young women
Providing evidence of a causal association between HPV infection and the acquisition of methylation changes in vivo is more problematic. Evidence adduced from cross-sectional surveys in patients with cervical intraepithelial neoplasia is unsatisfactory in so far as this study design cannot distinguish those methylation changes that are a consequence of the disease process from those that are directly attributable to the exposure. To establish a chain of causality linking HPV exposure to a given epigenetic change and to a particular disease outcome requires the generation of longitudinal observations in women who are both disease-free and HPV negative at the beginning of the period of observation. We were able to explore the temporal relationship between the first detection of cervical HPV infection and the subsequent appearance of methylation changes in a cohort of young women (methods section QV). We chose as our candidate genes for our in vivo methylation studies, the TSG, RARB and CADM1, methylated forms of which have been consistently detected in cervical samples taken from women with intraepithelial and invasive cervical disease (49, 50) , In 17 of the 21 women who were found to have had an incident HPV16 infection using nested Q-PCR, the number of methylated forms of RARB/10 000 cells detected using nested Q-MSP was found to be higher in the first HPV positive sample than in the HPV negative sample immediately preceding it (Wilcoxon-ranked sign test, P 5 0.0072, Table IV ). In 16 women, HPV viral load either returned to zero or decreased in the second of their last two HPV positive samples taken before the end of follow-up. In 13 of these women, the decrease in viral load in the second of these two samples was associated with a contemporaneous decrease in the number of methylated forms of RARB/10 000 cells (Wilcoxon-ranked sign test, P 5 0.0213, Table IV ). In two of the three women in whom there was no decrease in the number of methylated forms of RARB following clearance of HPV16 infection, both had a concurrent HPV18 infection which persisted beyond that visit at which HPV16 could no longer be detected (data not shown). Thus, changes in the number of methylated forms of RARB in clinical samples mirrored changes in HPV copy number. They are also consistent with those observed in our in vitro models. Following transfection of keratinocytes with episomal HPV16 and HPV18, Q-MSP revealed that the number of methylated forms of RARB increased from 183/10 000 cells to 2839 and 3851/10 000 cells, respectively; these values lie within the range found in our clinical samples. A smaller number of samples were also tested for methylated forms of the TSG, CADM1, methylated forms of which have been detected in women with CIN (16) . However, although Q-MSP confirmed an increase in the number of methylated forms of CADM1 from 419/10 000 cells to 6738 and 4552/10 000 cells following transfection of PHFK with episomal HPV16 and HPV18, respectively, we found no compelling evidence to suggest that the number of these forms of this gene in clinical samples vary with either the first detection or the subsequent clearance of HPV DNA (data not shown).
Discussion
We have shown that the transfection of PHFK with episomal forms of two high-risk HPV types is followed by widespread methylation changes in cellular genes, many of which are reported to be differentially methylated in cervical neoplasia. Consistent with observations that the HPV16 E7 oncoprotein can augment DNMT1 activity we have shown using organotypic raft cultures that HPV18 modulates the expression of both DNMT1 and DNMT3B (12) . Deregulation of DNMT1 and DNMT3B expression is also seen in HPV16 and HPV18-associated CIN3. We found DNMT1 to be consistently upreg- (51) , and DNMT3B to be expressed in all layers unlike normal epithelium where it is restricted to nuclei of basal and parabasal cells (Supplementary Figure S3 is available at Carcinogenesis Online). As the HPV genome does not code for a DNA methyltransferase, changes in the viral methylome are likely to be dependent on the cell's DNA methylation machinery. However, it has yet to be defined as to how HPVinduced changes in the activity of the DNA methyltransferases might explain the progressive increase in DNA methylation content in tissue taken from women who are HPV positive in the absence of any evidence of clinical disease, through those with CIN, to those with cervical carcinoma (52, 53) . Recently, it has also been suggested that in order to ensure continuing cell viability, HPV 'self-methylates', thus downregulating excessive oncogene activity (54). Our observations also, for the first time, point to a pattern of HPV-induced instructive methylation of cellular genes. HPV16-and HPV18-associated changes were not randomly distributed across the genome but clustered at certain chromosomal locations directed in part by the same cis-acting factors that appear to direct methylation changes in cancer, the presence of a bivalent chromatin mark in HES cells and promoter CpG content.
These cis-acting factors also appear to explain much of the ontological profile of the methylation changes observed following the transfection of high-risk HPV types. For example, the top 10 signalling pathways over-represented among genes with increased methylation following transfection of PHFK with HPV16 are also enriched for genes with a high CpG content and for those bivalently marked in HES cells (Supplementary Table S6A is available at Carcinogenesis Online). They include the WNT signalling pathway, components of which have been shown to be silenced by DNA methylation in cervical neoplasia (26) . Similarly, of the top 10 biological processes over-represented among genes hypermethylated following HPV16 transfection, all were enriched for genes bivalently marked in HES, and eight were enriched for genes with a high CpG content (Supplementary Table S6B is available at Carcinogenesis Online). On the other hand, of the top 10 biological processes that were significantly under-represented among genes which were hypermethylated following HPV16 transfection, all were found to be significantly depleted for genes with a high CpG content; these processes included antigen presentation and processing, cellular defence, immune response and complement activation (Supplementary   Table S6C is available at Carcinogenesis Online). Given the evolutionary pressure to lose CpG content, it is tempting to speculate that the low CpG content of many immune response genes may have evolved to offer some protection against virus-induced deregulation of the DNA methylation machinery. A more restricted set of pathways and biological processes were found to be enriched significantly among genes which were hypomethylated following HPV16 transfection (Supplementary  Table S7 is available at Carcinogenesis Online).
We have also shown using genome-wide methylation analysis that infection of germinal centre B cells with another oncogenic virus, EBV, imposes a similar pattern of instructive methylation (55) . Although the distribution of EBV-associated hotspots differed from that observed following transfection of PHFK with high-risk HPV types, the risk of these virus-associated methylation changes was also found to vary significantly with CpG content. It has also been suggested that aberrant de novo DNA methylation is, in part, dictated by underlying sequence context of CpG islands. Of the 1639 CpG islands classified as methylation prone by McCabe et al. (2009) , using an algorithm that integrates seven DNA sequence patterns with a marker of polycomb repressive complex 2 occupancy (SUZ12), 918 were listed on the Affymetrix promoter array (56) . Of these CpG islands, 529 and 228 were found to have increased methylation in HPV16-and HPV18-transfected cells, respectively. However, as this represents only a small proportion of those genes found to have increased methylation following transfection with these high-risk HPV types, other sequence-specific markers of methylation susceptibility may yet be identified.
Although most attention has focused on the epigenetic consequences of the insertion of foreign DNA into mammalian genomes and their contribution to oncogenic transformation, our results at least raise the as yet unproven possibility that methylation hotspots may be more susceptible to later genetic events. It will be of interest to relate the site of any viral integration event, or of chromosomal loss, which occur on long-term culture of these cell lines to the distribution of these early methylation changes. Furthermore, HPV-associated hypermethylation hotspots appear to cluster in telomeric regions (Figure 3) . This is also of interest not only because large-scale epigenomic alterations localized to these regions have been reported in cancer but also because methylation of transcriptionally repressive sequences in the hTERT promoter and proximal exonic sequences is associated 
HPV-induced methylation changes
with deregulated hTERT transcription in HPV-immortalized cells and cervical cancer cells (57, 58) . Of course, it could be argued that we have described only those methylation changes in cellular genes that follow the transfection of keratinocytes from a single donor, albeit with two high-risk HPV types, and that some of the observed changes are potentially unique to that donor. Genome-wide profiling of other keratinocytes from other donors would almost certainly reveal another set of methylation changes, some of which would be common to those we have already observed, whereas others would be different. Supplementary Figure 1 , available at Carcinogenesis Online, confirms that some methylation changes are consistently observed following transfection of keratinocytes from other donors infected with episomal forms of the same HPV type, whereas others are not. This heterogeneity reflects that observed in vivo where no single TSG has ever been shown to be methylated in more than 50% of the cervical cancers sampled. Similarly, it would be unreasonable to expect that all genes reported to be methylated in cervical neoplasia will necessarily be methylated following the transfection of keratinocytes with high-risk HPV types; some of the changes observed in vivo will be secondary to the onset of a disease process that it must be remembered is not an inevitable consequence of infection with high-risk HPV types. It should also be remembered that although our in vitro models of viral replication may be informative with respect to the acquisition of virus-induced epigenetic changes, only limited inferences can be drawn from these simple unidirectional models about the natural history of epigenetic changes associated with cervical HPV infection which more often than not is a self-limiting infection.
However, we have shown for the first time in vivo albeit in a small series, an association between the onset of infection with an oncogenic virus in young women who have recently embarked on sexual activity, and an increase in the detection of methylated forms of a TSG. Such inferences cannot be drawn from cross-sectional studies where there is always some temporal ambiguity about the relationship between exposure and disease, and which if performed in diseased subjects, may be confounded by changes secondary to the disease process. It remains to be determined whether the detection of methylated forms of RARB or of other TSG can refine the increased risk of high-grade CIN in women in this cohort who tested positive for high-risk HPV types. We also plan to explore using samples from this cohort the impact of infection with high-risk HPV types on the methylation of cellular genes and the relationship of these changes to the acquisition of disease. We found no evidence to suggest that HPV16 infection in these young women was followed by increased methylation of CADM1 consistent with the results of a recent cross-sectional study (16) . However, this finding does not exclude the possibility that the detection of methylated forms of CADM1 in cervical smears may still be a useful marker of disease status.
We also found that in many cases, 'clearance' of HPV16 infection was associated with a sharp decline in the detection of methylated forms of RARB and that in others, 'persistence' of infection was associated with the continuing detection of these methylated forms. This is of interest because the ectopic expression of RARβ2 has been shown to downregulate HPV18 transcription by selectively abrogating the binding of AP-1 to the viral regulatory region in a ligand-independent manner (59).
These observations may also have implications for attempts to improve the efficiency of cervical screening programmes using such DNA methylation markers. If the length of time during which methylated forms of these genes can be detected merely reflects the natural history of viral infection, then their detection might at first glance appear to offer no advantage over HPV testing. An analogous scenario may be seen in patients infected with Helicobacter pylori in whom reduced levels of TSG methylation follow successful eradication treatment (60, 61) . In both the gastric and cervical mucosa, cell turnover will result in the disappearance of methylated forms following clearance of infection when these forms are restricted to progenitor and differentiating cells. However, the continuing detection of these methylated forms following clearance of HPV infection may indicate their presence in stem cells or alternatively, a continuing exposure to some other methylating agent, for example, smoking which we have also shown to increase the risk of detection of another TSG, CDKN2A in this population (62) .
Establishing a chain of causality linking an environmental or a behavioural exposure such as HPV infection to a given methylation change and to a particular disease outcome in vivo is problematic. To do so, it is first necessary to show that the exposure can induce methylation changes in disease-free individuals (we have been able to reveal evidence for such an association in our preliminary analysis of our study cohort). Thereafter, it will be necessary to show that exposure-induced changes 'explain' at least some of the subsequent risk of disease. Only by generating longitudinal observations in disease-free subjects can the risk of incident and progressive disease associated with exposure-induced methylation changes be estimated. It is also possible that the onset of incident disease may itself herald a cascade of secondary methylation events, some of which may actually be better markers of disease progression. For no site of cancer has the risk of incident disease in disease-free individuals, or the risk of disease progression in those with pre-malignant changes, been related to the presence of epigenetic changes in baseline material. However, the accessibility of the cervix uteri and the acceptability of the sampling process does provide the opportunity for the repeated observations that are required. As cervical cancer has a clearly defined pre-malignant stage in which outcomes can be accrued within an acceptable time-frame, it is a useful model for exploring how epigenetic changes induced by behavioural and environmental risk factors, e.g. HPV infection and cigarette smoking, contribute to the initiation and progression of disease.
